Physician profile
Lori A Quick
NPI 1457302317
$3,348.92
in general payments reported to CMS, 2019-2025
21 companies · $769 in 2025
The $769 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $546 · 2022: $874 · 2023: $670 · 2024: $489 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,928.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $1,045.26 | 2021-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $694.28 | 2021-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $613.94 | 2022-2025 | Relistor |
| Vertos Medical, INC. | $133.34 | 2022-2023 | Mild Device Kit |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $103.68 | 2025 | Lokelma |
| Si-Bone, INC. | $90.40 | 2022-2025 | |
| Biodelivery Sciences International, INC. | $87.80 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $87.10 | 2025 | |
| Almatica Pharma LLC | $61.30 | 2022 | |
| Valinor Pharma, LLC | $43.17 | 2024 | Movantik |
| Grt US Holding, INC. | $42.12 | 2021 | |
| Medtronic, INC. | $39.25 | 2023 | Intellis Adaptivestim |
| Forte Bio-Pharma LLC | $37.92 | 2021 | |
| Hikma Pharmaceuticals USA | $29.77 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $24.74 | 2021 | |
| Averitas Pharma INC. | $22.10 | 2025 | Qutenza |
| Ermi LLC | $20.23 | 2025 | |
| Fidia Pharma USA INC. | $19.61 | 2023 | Hymovis |
| Globus Medical, INC. | $16.88 | 2025 | Senza |
| Foundation Fusion Solutions, LLC | $11.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Quick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.